Home › Metastatic Cancer › New York › Albany
Metastatic Cancer clinical trials in Albany, NY
4 studies for Metastatic Cancer are looking for participants at sites in and around Albany (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- NYOH Albany Cancer Center, Albany
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- New York Oncology Hematology, Albany
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecruitingPhase 3
- NYOH Albany Cancer Center, Albany
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
- New York Oncology Hematology, P.C., Albany
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Albany
- Non-Small Cell Lung Cancer9 studies
- Cardiovascular Disease7 studies
- Heart Failure6 studies
- Obesity6 studies
- Cancer (all types)5 studies
- Stroke4 studies
- High Blood Pressure4 studies
- Burkitt Lymphoma4 studies
- Multiple Myeloma4 studies
- Alzheimer's Disease4 studies
- Digestive Diseases4 studies
- Bladder Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.